Literature DB >> 3552255

Antireceptor antibodies in the study of EGF-receptor interaction.

L H Defize, C L Mummery, W H Moolenaar, S W de Laat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3552255     DOI： 10.1016/0045-6039(87)90423-4

Source DB:  PubMed          Journal:  Cell Differ        ISSN： 0045-6039


× No keyword cloud information.
  4 in total

1.  Differential expression of estrogen, progesterone, and epidermal growth factor receptors in normal, benign, and malignant human breast tissues using dual staining immunohistochemistry.

Authors:  T van Agthoven; M Timmermans; J A Foekens; L C Dorssers; S C Henzen-Logmans
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

2.  Occurrence of epidermal growth factor receptors in benign and malignant ovarian tumors and normal ovarian tissues: an immunohistochemical study.

Authors:  S C Henzen-Logmans; M E van der Burg; J A Foekens; P M Berns; R Brussée; J H Fieret; J G Klijn; S Chadha; C J Rodenburg
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

3.  Signal transduction by epidermal growth factor occurs through the subclass of high affinity receptors.

Authors:  L H Defize; J Boonstra; J Meisenhelder; W Kruijer; L G Tertoolen; B C Tilly; T Hunter; P M van Bergen en Henegouwen; W H Moolenaar; S W de Laat
Journal:  J Cell Biol       Date:  1989-11       Impact factor: 10.539

4.  A431 cell variants lacking the blood group A antigen display increased high affinity epidermal growth factor-receptor number, protein-tyrosine kinase activity, and receptor turnover.

Authors:  L H Defize; D J Arndt-Jovin; T M Jovin; J Boonstra; J Meisenhelder; T Hunter; H T de Hey; S W de Laat
Journal:  J Cell Biol       Date:  1988-09       Impact factor: 10.539
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.